Guardant Health is a pioneer in non-invasive cancer diagnostics and the first company to commercialize a comprehensive genomic liquid biopsy. The Company's proprietary digital sequencing technology is transforming cancer treatment by providing an accurate and precise picture of the individual genomic alterations that cause tumors to grow, change, and develop resistance to treatment.
Latest funding size
Time since last funding
|Sequoia Capital, Lightspeed Venture Partners, Khosla Ventures, Bobby Yazdani, T. Rowe Price, Pejman Mar Ventures, Temasek Holdings, Formation 8, Heritage Group, OrbiMed Advisors, Felicis Venture, Softbank, OrbiMed, 8VC|